JP2002521334A - 置換ベンズイミダゾール抗ウィルス剤 - Google Patents

置換ベンズイミダゾール抗ウィルス剤

Info

Publication number
JP2002521334A
JP2002521334A JP2000560893A JP2000560893A JP2002521334A JP 2002521334 A JP2002521334 A JP 2002521334A JP 2000560893 A JP2000560893 A JP 2000560893A JP 2000560893 A JP2000560893 A JP 2000560893A JP 2002521334 A JP2002521334 A JP 2002521334A
Authority
JP
Japan
Prior art keywords
alkyl
ylmethyl
embedded image
benzimidazol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2000560893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002521334A5 (enExample
Inventor
クオ ロング ユー
リタ リー シヴィエロ
マーク アール クリスタル
キャスリーン エフ カドー
ニコラス エイ ミーンウェル
Original Assignee
ブリストルーマイヤーズ スクイブ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブリストルーマイヤーズ スクイブ カンパニー filed Critical ブリストルーマイヤーズ スクイブ カンパニー
Publication of JP2002521334A publication Critical patent/JP2002521334A/ja
Publication of JP2002521334A5 publication Critical patent/JP2002521334A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2000560893A 1998-07-20 1999-07-20 置換ベンズイミダゾール抗ウィルス剤 Abandoned JP2002521334A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9338798P 1998-07-20 1998-07-20
US60/093,387 1998-07-20
PCT/US1999/012398 WO2000004900A1 (en) 1998-07-20 1999-07-20 Substituted benzimidazole antiviral agents

Publications (2)

Publication Number Publication Date
JP2002521334A true JP2002521334A (ja) 2002-07-16
JP2002521334A5 JP2002521334A5 (enExample) 2006-08-17

Family

ID=22238648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000560893A Abandoned JP2002521334A (ja) 1998-07-20 1999-07-20 置換ベンズイミダゾール抗ウィルス剤

Country Status (6)

Country Link
US (2) US6908936B2 (enExample)
EP (1) EP1098644A1 (enExample)
JP (1) JP2002521334A (enExample)
AU (1) AU741946B2 (enExample)
CA (1) CA2338147A1 (enExample)
WO (1) WO2000004900A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528564A (ja) * 2005-01-31 2008-07-31 アロウ セラピューティクス リミテッド 抗ウイルス剤としてのキナゾリン誘導体
JP2011503136A (ja) * 2007-11-15 2011-01-27 エフ．ホフマン−ラ ロシュ アーゲー ベンゾイミダゾール誘導体及びｆｘｒアゴニストとしてのその使用
JP2020532494A (ja) * 2017-07-20 2020-11-12 アールイーヴァイラル リミテッド 医薬化合物

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011997A (pt) 1999-06-28 2002-03-05 Janssen Pharmaceutica Nv Inibidores da replicação do vìrus sincicial respiratório
CA2407292A1 (en) * 2000-05-03 2001-11-08 Medimmune, Inc. Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
CA2494485A1 (en) * 2002-07-25 2004-02-05 Medimmune, Inc. Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
US7157471B2 (en) * 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
JP4537407B2 (ja) 2003-10-30 2010-09-01 ベーリンガー インゲルハイム （カナダ） リミテッド Ｒｓｖポリメラーゼインヒビター
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
EP1928465A1 (en) 2005-09-19 2008-06-11 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
GB0520475D0 (en) * 2005-10-07 2005-11-16 Arrow Therapeutics Ltd Chemical compounds
BRPI0706412A2 (pt) * 2006-01-11 2011-03-29 Arrow Therapeutics Ltd composto, uso de um composto, produto, composição farmacêutica, uso de um interferon ou um derivado de interferon, e, método de tratamento de um paciente sofrendo ou susceptìvel a infecção por flaviviridae
WO2009029622A2 (en) * 2007-08-27 2009-03-05 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
JP6118470B2 (ja) 2013-12-10 2017-04-19 南京明徳新薬研発股▲分▼有限公司 抗ウイルス剤として使用されるイミダゾール誘導体及び該イミダゾール誘導体の薬剤の製造における使用
CN107709328B (zh) 2015-06-08 2021-03-05 山东丹红制药有限公司 咪唑衍生物及其中间体的制备方法和晶型
CN105820156A (zh) * 2016-04-21 2016-08-03 广东工业大学 苯并三氮唑基苯并咪唑啉及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394141A (en) 1965-11-12 1968-07-23 Fabio Sparatore Z-benzyaminobenzimidazoles
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
DK154078C (da) 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
CA2197393A1 (en) 1996-02-13 1997-08-14 Yakov Gluzman (Deceased) Triazine containing anionic compounds useful as antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528564A (ja) * 2005-01-31 2008-07-31 アロウ セラピューティクス リミテッド 抗ウイルス剤としてのキナゾリン誘導体
JP2011503136A (ja) * 2007-11-15 2011-01-27 エフ．ホフマン−ラ ロシュ アーゲー ベンゾイミダゾール誘導体及びｆｘｒアゴニストとしてのその使用
JP2020532494A (ja) * 2017-07-20 2020-11-12 アールイーヴァイラル リミテッド 医薬化合物

Also Published As

Publication number Publication date
US20030139450A1 (en) 2003-07-24
EP1098644A1 (en) 2001-05-16
AU741946B2 (en) 2001-12-13
CA2338147A1 (en) 2000-02-03
US20050038085A1 (en) 2005-02-17
WO2000004900A1 (en) 2000-02-03
US6908936B2 (en) 2005-06-21
AU5080999A (en) 2000-02-14
US7030140B2 (en) 2006-04-18

Similar Documents

Publication Publication Date Title
JP2002521334A (ja) 置換ベンズイミダゾール抗ウィルス剤
US6506738B1 (en) Benzimidazolone antiviral agents
US6774134B2 (en) Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
TWI423963B (zh) 可用於治療ｃ型肝炎之化合物之合成方法
JP2868313B2 (ja) Ｎ−置換複素環誘導体およびその製法
US6489338B2 (en) Imidazopyridine and imidazopyrimidine antiviral agents
US5866589A (en) Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds
DE60008372T2 (de) Pharmazeutisch aktive verbindungen
EP1142879B1 (en) Imidazole compounds and medicinal use thereof
FI100969B (fi) Menetelmä valmistaa terapeuttisesti aktiivista pyratsolo£1,5-a|pyridii niyhdistettä
CZ296163B6 (cs) Karboxyamidy chinolinu jako inhibitory TNF a inhibitory PDE-IV
BG99111A (bg) Индолови производни
SK287919B6 (sk) Indolylmaleimide derivatives, method for the preparation thereof and pharmaceutical composition comprising same
JP2010513386A5 (enExample)
US5977136A (en) Tetrahydroquinolines as NMDA antagonists
HUT74678A (en) Imidazo[1,2-a]pyrazine-4-one, preparation thereof and drugs containing same
CZ20023967A3 (cs) Deriváty 3-azabicyklo[3,1,0]hexanu vykazující afinitu k opiátovým receptorům
HU203345B (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising same
JPWO1997000258A1 (ja) 三環性ベンゾアゼピン化合物
CN101142208B (zh) 作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺
EP1095039B1 (en) New pharmaceutically active compounds
FI107155B (fi) Menetelmä farmakologisesti käyttökelpoisten 1-(imidatso[1,2-a]pyridin-6-yyli)-sykloheksaanikarbotioamidijohdannaisten valmistamiseksi
US5624948A (en) 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
HK1214244A1 (zh) 咪唑并吡啶衍生物
US20030207876A1 (en) 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060622

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20061221